Breakthrough cryptococcosis in a patient with systemic lupus erythematosus (SLE) receiving micafungin
Authors:
- 1 January 2008
- journal article
- case report
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 14 (4) , 311-314
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Micafungin: A New Echinocandin AntifungalPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Micafungin: A New EchinocandinClinical Infectious Diseases, 2006
- Breakthrough Trichosporonosis in Patients with Hematologic Malignancies Receiving MicafunginClinical Infectious Diseases, 2006
- Breakthrough trichosporonosis in patients with acute myeloid leukemia receiving micafunginLeukemia & Lymphoma, 2006
- Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2004
- In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important FungiAntimicrobial Agents and Chemotherapy, 2000
- Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcomeJournal of Antimicrobial Chemotherapy, 1998
- In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolatesAntimicrobial Agents and Chemotherapy, 1997
- Cryptococcal meningitis in systemic lupus erythematosusSeminars in Arthritis and Rheumatism, 1992